Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

INVO Fertility (IVF) Cost of Revenue (2016 - 2025)

INVO Fertility (IVF) has disclosed Cost of Revenue for 15 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 14.09% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.2 million, a 17.36% increase, with the full-year FY2024 number at $3.7 million, up 89.09% from a year prior.
  • Cost of Revenue was $1.1 million for Q3 2025 at INVO Fertility, up from $1.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.1 million in Q3 2025 to a low of $9732.0 in Q2 2021.
  • A 5-year average of $491943.7 and a median of $235714.0 in 2023 define the central range for Cost of Revenue.
  • Biggest YoY gain for Cost of Revenue was 923.21% in 2021; the steepest drop was 48.07% in 2021.
  • INVO Fertility's Cost of Revenue stood at $54588.0 in 2021, then soared by 105.34% to $112093.0 in 2022, then skyrocketed by 691.08% to $886750.0 in 2023, then rose by 7.97% to $957419.0 in 2024, then increased by 17.79% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Cost of Revenue are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.0 million (Q1 2025).